DHT and Hair Loss in India — The Real Reason Your Hair Is Thinning
Share
DHT and Hair Loss in India — The real reason your hair is thinning
Most people treating hair fall are treating the symptom. DHT is the cause. Here's the biology behind it, who it's affecting, and what the evidence says about actually addressing it.
Shampoo for hair fall. Oil for hair fall. Supplements for hair fall. The Indian hair care market has an answer for every symptom. What it rarely explains is the mechanism causing the symptom in the first place.
For the majority of people experiencing progressive hair thinning — men and women — the mechanism is DHT. Dihydrotestosterone. A hormone your body makes naturally, whose relationship with your hair follicles becomes destructive under specific conditions.
This post is about understanding that mechanism clearly — because you can't address something you don't understand. We'll go through what DHT is, how it causes hair loss, who it affects, what the research says works, and what it honestly doesn't.
Section 01
What DHT actually is — and what it's supposed to do.
DHT — dihydrotestosterone — is an androgen hormone. Androgens are the class of hormones responsible for male characteristics, though women produce them too, in smaller amounts. DHT is made from testosterone through an enzyme called 5-alpha reductase (5-AR). This enzyme converts a portion of your circulating testosterone into DHT.
DHT has legitimate biological functions. In foetal development, it drives the formation of male genitalia. During puberty, it's involved in body hair growth, muscle development, and prostate maturation. It's not a harmful hormone in itself — it becomes a problem when it interacts with hair follicles in specific genetic circumstances.
The basic biochemistry
Testosterone → 5-alpha reductase enzyme → DHT. There are two types of 5-AR: Type 1 (present mainly in skin and liver) and Type 2 (present mainly in hair follicles and the prostate). Type 2 is the primary driver of follicle-level DHT activity. This distinction matters because it explains why some DHT-inhibiting treatments work specifically on hair follicles without shutting down all androgenic activity in the body.
DHT is significantly more potent than testosterone — it binds to androgen receptors roughly 3–5 times more strongly. When it binds to androgen receptors in hair follicles that have a genetic sensitivity to it, it begins a process of follicle miniaturisation that eventually leads to hair loss.
Section 02
How DHT actually destroys a hair follicle — step by step.
This is the mechanism most hair care brands never explain. Understanding it is the difference between treating your hair loss intelligently and buying products that address none of the actual biology.
DHT binds to the androgen receptor in the follicle
Every hair follicle contains androgen receptors — proteins that bind to androgens like testosterone and DHT. In follicles that have a genetic sensitivity to DHT, this binding triggers a damaging cascade. Follicles on the top and front of the scalp tend to have more androgen receptors and higher sensitivity than follicles on the sides and back — which is why pattern hair loss follows predictable pathways.
The growth phase (anagen) shortens
Normal hair follicles cycle through three phases: anagen (active growth, lasting 2–6 years), catagen (transition), and telogen (rest, then shedding). When DHT binds to a sensitive follicle, it shortens the anagen phase. Instead of growing for years, each hair grows for months — and each subsequent cycle the anagen phase gets shorter.
The follicle miniaturises
As anagen shortens, the hair shaft produced gets progressively thinner and shorter — a process called follicle miniaturisation. Terminal hairs (thick, pigmented, long) regress into vellus hairs (thin, colourless, barely visible). This is why hair loss often appears gradual — the follicle doesn't die immediately, it downgrades over multiple cycles across years.
The follicle eventually becomes dormant
If DHT exposure continues unchecked over years, the follicle can become permanently dormant — unable to produce a hair shaft at all. At this point, topical treatments have very limited ability to reverse the damage. This is the window that matters: addressing DHT activity before follicles reach dormancy is the entire point of early intervention.
Result: Androgenetic alopecia
The clinical name for this progressive, DHT-driven hair loss is androgenetic alopecia. It is the most common cause of hair loss worldwide — affecting an estimated 50% of men and 30% of women by age 50. In India, increasing urbanisation, dietary changes, and chronic stress are thought to be accelerating its onset.
Most people realise something is wrong at cycle 3 or 4 — years after DHT started shortening the anagen phase. The follicle has been degrading quietly the entire time.
Section 03
Who it affects — and why India has a specific problem here.
Androgenetic alopecia is genetic — but the gene isn't only inherited from the mother's side, as the popular myth suggests. It's polygenetic, meaning it involves multiple genes from both parents. If pattern hair loss appears on either side of your family, your follicles may carry the sensitivity.
Men with pattern loss
Receding hairline, thinning crown, or both — following the Hamilton-Norwood scale. DHT sensitivity is the primary driver. Onset can begin as early as the early twenties.
Women with diffuse thinning
Female pattern hair loss typically presents as diffuse thinning over the crown, not recession. Post-pregnancy and perimenopause are common onset windows because oestrogen — which partially counters DHT — drops significantly in both states.
People under chronic stress
Cortisol — the stress hormone — upregulates 5-alpha reductase activity. Elevated chronic stress in India's urban population is genuinely increasing DHT activity in people who might otherwise have managed their genetic sensitivity without significant hair loss.
Post-pregnancy women
Post-partum hair loss involves both the withdrawal of oestrogen protection and elevated cortisol from sleep deprivation and physical recovery. The DHT mechanism becomes more active in this window than at most other points in a woman's life.
"The Indian urban context — chronic stress, disrupted sleep, dietary shifts away from nutrient-dense foods — creates near-ideal conditions for early-onset androgenetic alopecia in people who carry the genetic sensitivity."
Section 04
Four things most people believe about DHT hair loss that aren't accurate.
Misinformation about hair loss is rampant — partly because the market benefits from keeping the science unclear. Here's what the evidence says.
Myth
"Hair loss is inherited only from your mother's side."
The gene most strongly associated with androgenetic alopecia (AR gene) is X-linked — meaning it is inherited from the mother. But pattern hair loss is polygenetic. Multiple genes from both parents contribute to the sensitivity. A father with significant hair loss is a meaningful predictor for his children — for both sons and daughters.
Myth
"High DHT means high testosterone — it's a sign of vitality."
DHT levels don't directly correlate with testosterone levels in a simple way. People with androgenetic alopecia don't necessarily have higher testosterone or DHT overall — they have follicles that are more sensitive to DHT at normal concentrations. The problem is receptor sensitivity, not necessarily hormone volume.
Myth
"Using oil and shampoo will stop DHT hair loss."
Standard oils and shampoos that don't contain specific DHT-inhibiting compounds have no meaningful effect on the hormonal mechanism driving androgenetic alopecia. They may improve scalp health, reduce breakage, and support general hair quality — but they don't address the androgen receptor activity that's shortening the anagen phase. This is why choosing what you apply to your scalp matters at the ingredient level.
Myth
"Once you start losing hair, nothing can stop it."
Early intervention meaningfully changes outcomes. Pharmaceutical DHT blockers like finasteride have decades of clinical data showing they slow and in many cases halt progression in the majority of users. Natural DHT-inhibiting compounds show more modest but real effects when applied consistently and at meaningful concentrations. The earlier the intervention, the more follicles are still in a reversible state.
Section 05
What the evidence says actually works — ranked honestly.
There is a spectrum here. Pharmaceutical interventions have the most clinical data. Natural approaches have growing evidence but more modest effects. Both have a role depending on severity and preference. Here is the honest hierarchy.
Finasteride (oral)
A Type 2 5-alpha reductase inhibitor taken orally. Reduces DHT in the scalp by approximately 70%. Multiple large randomised controlled trials show significant slowing of hair loss and regrowth in the majority of users. Prescription only in India. Side effects exist and should be discussed with a doctor — sexual function side effects affect a minority of users.
Minoxidil (topical or oral)
Not a DHT blocker — works by extending the anagen phase and improving blood flow to follicles. Strong clinical evidence. Most effective when combined with a DHT-blocking approach. Available OTC in India at 2% and 5% concentrations. Requires consistent use — stopping causes regression.
Rosemary Extract (topical)
Inhibits 5-alpha reductase topically. A 2015 randomised trial found rosemary oil statistically comparable to minoxidil 2% for hair count at six months. Effect is concentration-dependent — trace amounts in most commercial products are unlikely to replicate clinical results. Best evidence among natural topical approaches. Requires sustained use.
Pumpkin Seed Oil (topical or oral)
Contains delta-7-stearine, a 5-AR inhibitor. A 2014 randomised controlled trial found oral pumpkin seed oil increased hair count by 40% over 24 weeks versus placebo. Topical evidence is more limited but the mechanism is established. Useful as a complementary DHT-blocking ingredient.
Saw Palmetto (oral supplement)
5-AR inhibitor. Some trials show modest benefit for androgenetic alopecia. Evidence is less consistent than pharmaceutical options. Well tolerated with fewer side effects than finasteride. A reasonable option for people who want a pharmaceutical-free approach and accept more modest results.
Scalp massage
A 2016 study found that standardised scalp massage increased hair thickness over 24 weeks. Mechanism is improved circulation and mechanical stretching of follicle cells. Not a DHT blocker — but a meaningful supporting intervention with essentially no downside. Compounding effects when combined with topical actives.
The honest framing
Pharmaceutical options (finasteride, minoxidil) have significantly more clinical data than natural approaches. If you have significant androgenetic alopecia and are comfortable with pharmaceuticals — a dermatologist's input on these options is worth getting before committing to a natural-only approach. Natural DHT inhibitors are meaningful as a preventive or complementary approach, or for people who prefer to avoid pharmaceuticals and accept more gradual, modest results.
Section 06
DHT hair loss versus other kinds — how to tell the difference.
Not all hair loss is androgenetic. Getting this wrong leads to treating the wrong problem. Here's how the main types differ.
Androgenetic Alopecia (DHT-driven)
Telogen Effluvium (stress/deficiency-driven)
If you're unsure which type you have — and many people have elements of both — a dermatologist can do a trichoscopy (scalp examination under magnification) and basic blood panel to identify the primary driver. Treating androgenetic alopecia when you have telogen effluvium, or vice versa, wastes time and money.
Frequently asked
Questions on DHT and hair loss — answered directly.
Can I check my DHT levels with a blood test?
Yes — DHT can be measured via a blood test. However, total serum DHT levels are often normal in people with androgenetic alopecia. The issue is follicle sensitivity to DHT, not necessarily elevated systemic DHT. A dermatologist examining your scalp and hair loss pattern is typically more useful than a blood test for diagnosing androgenetic alopecia. Blood tests are more useful for ruling out other causes — thyroid, ferritin, iron.
Does stress actually cause DHT hair loss or is that a myth?
Both. Acute stress primarily causes telogen effluvium — pushing follicles into the resting phase and causing diffuse shedding. But chronic stress upregulates cortisol, which in turn increases 5-alpha reductase activity — directly increasing DHT production. So long-term chronic stress can genuinely accelerate androgenetic alopecia in people who carry the genetic sensitivity. It's a real mechanism, not a myth.
If I stop my hair fall treatment, will the hair I kept fall out?
For pharmaceutical DHT blockers like finasteride — yes, stopping allows DHT activity to resume and the progression that was paused will continue. Hair retained by the treatment may eventually be lost. This is well-documented and is one of the main reasons dermatologists emphasise that treatment, once started for androgenetic alopecia, is typically long-term. Natural DHT inhibitors likely follow a similar pattern at a slower rate.
Can women use DHT-blocking treatments meant for men?
Finasteride is generally not recommended for women of childbearing age due to potential effects on foetal development. Topical minoxidil at 2% is approved for women. Natural topical DHT inhibitors (rosemary, pumpkin seed) have no such restriction. Women with androgenetic alopecia should discuss pharmaceutical options with a dermatologist or gynaecologist who can account for their individual hormonal context.
How early is too early to start treating hair loss?
There's no such thing as too early when the mechanism is active. Every follicle miniaturisation cycle that happens before intervention is a cycle that moved the follicle closer to dormancy. Starting a DHT-inhibiting regimen — even a conservative, natural one — at the first signs of thinning preserves the maximum number of follicles in a reversible state. The time to act is when you first notice it.
A note from Anther
We wrote this post because we think the science behind hair loss deserves to be explained plainly — without it being a sales pitch. DHT is the mechanism behind most hair loss in India. Understanding it is the first step to addressing it intelligently, whether that means a conversation with a dermatologist, a pharmaceutical treatment, a natural topical approach, or some combination.
If you're looking for a natural topical option built specifically around DHT inhibition — our Hair Growth Oil contains three independent DHT-blocking actives at clinically relevant concentrations. It's not a replacement for pharmaceutical treatment in severe cases, and we say that clearly. But for early-stage pattern loss and as a complement to other approaches, the formulation is built around exactly the mechanism this post describes.
Read the science. Make the decision that's right for your situation.
References
Kaufman KD (2002). Androgens and alopecia. Mol Cell Endocrinol, 198(1–2):89–95.
Panahi Y et al. (2015). Rosemary oil vs minoxidil 2% for androgenetic alopecia: a randomised comparative trial. SKINmed, 13(1):15–21.
Cho YH et al. (2014). Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia. Evidence-Based Complementary and Alternative Medicine.
Dhariwala MY & Ravikumar P (2019). An overview of herbal alternatives in androgenetic alopecia. J Cosmet Dermatol, 18(4):966–975.
Koyama T et al. (2016). Standardized scalp massage results in increased hair thickness. Eplasty, 16:e8.
Sinclair R et al. (2015). Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res, 4(F1000 Faculty Rev):585.